Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Read more about Correction to: LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Read more about Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel.
Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study. Read more about Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study.
Dual-energy CT workflow: multi-institutional consensus on standardization of abdominopelvic MDCT protocols. Read more about Dual-energy CT workflow: multi-institutional consensus on standardization of abdominopelvic MDCT protocols.
Benefit of iodine density images to reduce out-of-field image artifacts at rapid kVp switching dual-energy CT. Read more about Benefit of iodine density images to reduce out-of-field image artifacts at rapid kVp switching dual-energy CT.
3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors. Read more about 3D T2-weighted and Gd-EOB-DTPA-enhanced 3D T1-weighted MR cholangiography for evaluation of biliary anatomy in living liver donors.
Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement. Read more about Multiple arterial phase MRI of arterial hypervascular hepatic lesions: improved arterial phase capture and lesion enhancement.
Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography. Read more about Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography.
Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy. Read more about Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.
